Neurotech Pharmaceuticals, Inc. is a privately held biotech company located in Cumberland, Rhode Island. Neurotech has spent years developing the science, technology, team and manufacturing behind NT-501. As a result of a unique partnership and clear direction, we are focused on bringing a long-term treatment to Macular Telangiectasia (MacTel) patients. Our team is focused on bringing to market this treatment designed to slow the progression of MacTel and the vision impairments it causes in patients who don't have another treatment option. Our goal is to help these patients sustain their quality of life.
View Top Employees from Neurotech Pharmaceuticals, Inc.Website | http://www.neurotechpharmaceuticals.com |
Employees | 78 (52 on RocketReach) |
Address | 900 Highland Corporate Drive Building 1, Suite 101, Building 1, Suite 101, Cumberland, Rhode Island 02864, US |
Industry | Biotechnology Research |
Looking for a particular Neurotech Pharmaceuticals, Inc. employee's phone or email?
Patricia Davis is the Vice President Clinical Operations of Neurotech Pharmaceuticals, Inc..
52 people are employed at Neurotech Pharmaceuticals, Inc..
Neurotech Pharmaceuticals, Inc. is based in Cumberland, Rhode Island.